Additional Proxy Soliciting Materials (definitive) (defa14a)
April 18 2018 - 12:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule
14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
|
|
|
Filed by the Registrant
|
|
☒
|
Filed by a Party other than the Registrant
|
|
☐
|
Check the appropriate box:
☐
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☐
|
Definitive Proxy Statement
|
☒
|
Definitive Additional Materials
|
☐
|
Soliciting Material Pursuant to § 240.14a-12
|
ARCA BIOPHARMA, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy
Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box)
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
1.
|
Title of each class of securities to which transaction applies:
|
2.
|
Aggregate number of securities to which transaction applies:
|
3.
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
|
4.
|
Proposed maximum aggregate value of transaction:
|
☐
|
Fee paid previously with preliminary materials.
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
|
6.
|
Amount Previously Paid:
|
7.
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
|
|
|
Vote by Internet
Go to
www.investorvote.com/ABIO
Or scan the QR code with your smartphone
Follow the steps outlined on the secure website
|
Important Notice Regarding the Availability of Proxy Materials for the
ARCA biopharma, Inc. Stockholder Meeting to be Held on May 31, 2018
Under Securities and Exchange Commission rules, you are receiving this notice that the proxy materials for the annual stockholders meeting are available on the
Internet. Follow the instructions below to view the materials and vote online or request a copy. The items to be voted on and location of the annual meeting are on the reverse side. Your vote is important!
This communication is not a form of voting and presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage
you to access and review all of the important information contained in the proxy materials before voting. The proxy statement and annual report to stockholders are available at:
|
|
|
|
|
Easy Online Access A Convenient Way to View Proxy Materials and Vote
When you go online to view materials, you can also vote your shares.
Step 1:
Go to
www.investorvote.com/ABIO
.
Step 2:
Click the
View
button(s) to access the proxy materials.
Step 3:
Return to the investorvote.com window and follow the instructions on the screen to log in.
Step 4:
Make your selection as instructed on each screen to select delivery preferences and vote.
|
When you go online, you can also help the environment by
consenting to receive electronic delivery of future materials.
|
|
|
|
|
Obtaining a Copy of the Proxy Materials If you want to receive a paper
or e-mail copy of these documents, you must request one. There is no charge to you for requesting a copy. Please make your request for a copy as instructed on the reverse side on or before May 21, 2018 to facilitate timely
delivery.
|
ARCA BIOPHARMA, INC.s Annual Meeting of Stockholders will be held on May 31, 2018 at the Renaissance Boulder Flatiron Hotel,
500 Flatiron Blvd., Broomfield, Colorado, 80021 at 9:00 a.m., Mountain Time. Directions to the meeting can be found at www.arcabiopharma.com.
Proposals to
be voted on at the meeting are listed below along with the Board of Directors recommendations.
The Board of Directors recommends that you vote
FOR
the nominees listed below in Proposal 1 and
FOR
Proposal 2.
|
1.
|
To elect two directors to hold office until the 2021 Annual Meeting of Stockholders.
|
01 - Raymond L.
Woosley
02 - Daniel J. Mitchell
|
2.
|
To ratify the selection of KPMG LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2018.
|
|
NOTE:
|
In their discretion the proxy holders are authorized to vote upon such other business as may properly come before the meeting or any adjournment thereof.
|
PLEASE NOTE YOU CANNOT VOTE BY RETURNING THIS NOTICE. To vote your shares you must vote online or request a paper copy of the proxy materials to receive a
proxy card. If you wish to attend and vote at the meeting, please bring this notice with you.
|
|
|
|
|
|
|
Heres how to order a copy of the proxy materials and select a future delivery preference:
|
|
Paper copies:
Current and future paper delivery requests
can be submitted via the telephone, Internet or email options below.
|
|
Email copies:
Current and future email delivery requests
must be submitted via the Internet following the instructions below. If you request an email copy of current materials you will receive an email with a link to the materials.
|
|
|
PLEASE NOTE:
You must use the numbers in the shaded bar on
the reverse side when requesting a set of proxy materials.
|
|
|
g
|
|
Internet
Go to
www.investorvote.com/ABIO.
Follow the instructions to log in and order a paper or email copy of the current meeting materials and submit your preference for email or paper delivery of future
meeting materials.
|
|
|
g
|
|
Telephone
Call us free of charge at 1-866-641-4276 using a
touch-tone phone and follow the instructions to log in and order a paper copy of the materials by mail for the current meeting. You can also submit a preference to receive a paper copy for future meetings.
|
|
|
g
|
|
Email
Send email to investorvote@computershare.com with
Proxy Materials ARCA BIOPHARMA, INC. in the subject line. Include in the message your full name and address, plus the four numbers located in the shaded bar on the reverse, and state in the email that you want a paper copy of current
meeting materials. You can also state your preference to receive a paper copy for future meetings.
|
|
|
|
|
To facilitate timely delivery, all requests for a paper or email copy of the
proxy materials must be received by May 21, 2018. You will not otherwise receive a paper or email copy.
|
|
|
02TQDC
|
ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
From May 2024 to Jun 2024
ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
From Jun 2023 to Jun 2024